EVIDENCE FOR HEALTHCARE IMPROVEMENT (EIN 463250612) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

SARAH EMOND

Phone

6175284013

Tax Period

2023-01-01 to 2023-12-31

EVIDENCE FOR HEALTHCARE IMPROVEMENT, founded in 2013, is a community nonprofit in the Health Care sector that reported $6.7M in total revenue in fiscal year 2023. Revenue fell 27% from the prior year — a significant decline worth monitoring. Expenses of $8.8M exceeded revenue, resulting in a 31% operating deficit.

Mission

BETTER HEALTH FOR ALL AMERICANS THROUGH SUSTAINABLE ACCESS TO HIGH-VALUE HEALTH CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $4,946,392

Program Service Revenue $1,345,102

Investment Income $96,228

Other Revenue $305,954

TOTAL REVENUE $6,693,676

Expense Breakdown

Grants Paid $0

Salaries & Benefits $5,210,247

Fundraising Expenses $187,962

Program Expenses $6,564,608

Other Expenses $3,573,463

TOTAL EXPENSES $8,783,710

Year-over-Year Comparison

	2023	2022	Change
Revenue	$6,693,676	$9,203,334	-0.3%
Expenses	$8,783,710	$9,318,450	-0.1%
Net Income	$-2,090,034	$-115,116	+17.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,255,160

Total Directors

$1,500

Key Employees

$790,223

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LEIGH PURVIS MPA	BOARD CHAIR	1.00	Officer Director	$0	$0	$0
ELLEN ANDREWS PHD	DIRECTOR	1.00	Director	$0	$0	$0
LINDA GOLER BLOUNT MPH	DIRECTOR	1.00	Director	$1,500	$0	$1,500
ROBERTA HERMAN MD	DIRECTOR	1.00	Director	$0	$0	$0
CHRIS JENNINGS	DIRECTOR	1.00	Director	$0	$0	$0
JOY LEWIS MSW MPH	DIRECTOR	1.00	Director	$0	$0	$0
MURRAY ROSS PHD	DIRECTOR	1.00	Director	$0	$0	$0
ANYA RADER WALLACK PHD	DIRECTOR	1.00	Director	$0	$0	$0
MARK SKINNER JD	DIRECTOR	1.00	Director	$0	$0	$0
STEVEN D PEARSON	PRESIDENT	40.00	Officer	$555,239	$46,392	$601,631
SARAH K EMOND	PRESIDENT-ELECT	40.00	Officer	$382,269	$39,604	$421,873
ELLIE ADAIR	COO	40.00	Officer	$220,177	$11,479	$231,656
FOLUSO AGBOOLA	VP OF RESEARCH	40.00	Key Emp	$188,864	$40,956	$229,820
JONATHAN CAMPBELL	SR VP HEALTH ECON. UNTIL 7/23	40.00	Key Emp	$180,947	$27,486	$208,433
DAVID RIND	CHIEF MEDICAL OFFICER	32.00	Key Emp	$305,856	$46,114	$351,970
MARIA LOWE	DIR. OF PHARMA. INTELLIGENCE	40.00	Highest	$148,710	$29,566	$178,276
ANITA CHAN	FINANCE DIRECTOR	40.00	Highest	$111,956	$16,615	$128,571
MEAGHAN CUMMINGS	SPECIAL ASSISTANT TO THE PRESIDENT	40.00	Highest	$113,850	$16,252	$130,102
CATHERINE KOOLA FISCHER	DIR. OF PATIENT ENGAGEMENT	40.00	Highest	$106,446	$15,202	$121,648
MAX LEE	PHARMACEUTICAL INTELLIGENCE MGR	40.00	Highest	$119,523	$11,249	$130,772

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$6,693,676	$8,783,710	$12,213,931	$-2,090,034
2022	$9,203,334	$9,318,450	$15,511,951	$-115,116
2021	$7,868,981	$9,192,421	$9,935,379	$-1,323,440
2020	$2,977,954	$7,859,747	$10,085,162	$-4,881,793
2019	$10,872,122	$6,710,011	$14,188,477	$4,162,111
2018	$2,104,041	$6,300,984	$9,910,517	$-4,196,943

EVIDENCE FOR HEALTHCARE IMPROVEMENT